Cargando…
A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients
Circulating cell-free(cf) microRNAs (miRNAs) have been reported to exist in plasma. MicroRNA-210(miR-210) is known to play important roles in the tumor hypoxic state. We hypothesized that the expression levels of cf-miR-210 in plasma would predict early clinical recurrence in melanoma patients. A di...
Autores principales: | Ono, Shigeshi, Oyama, Takashi, Lam, Stella, Chong, Kelly, Foshag, Leland J., Hoon, Dave S.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466669/ https://www.ncbi.nlm.nih.gov/pubmed/25749524 |
Ejemplares similares
-
Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
por: Ono, Shigeshi, et al.
Publicado: (2015) -
Correction: Ono, S.; Lam, S.; Nagahara, M.; Hoon, D.S.B. Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J. Clin. Med. 2015, 4, 1890–1907
por: Ono, Shigeshi, et al.
Publicado: (2016) -
Hypoxia-Induced MicroRNA-210 Targets Neurodegenerative Pathways
por: Watts, Michelle E., et al.
Publicado: (2018) -
Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients
por: Ramos, Romela Irene, et al.
Publicado: (2020) -
Effect of Hypoxia-Induced MicroRNA-210 Expression on Cardiovascular Disease and the Underlying Mechanism
por: Guan, Yinuo, et al.
Publicado: (2019)